Robert Baird, RN, MSA, president of the National Cancer Treatment Alliance, discusses potential issues employers can avoid by direct contracting with providers.
Robert Baird, RN, MSA, president of the National Cancer Treatment Alliance, discusses potential protections self-insured employers could seeing from direct contracting, including the elimination of tactics from pharmacy benefit managers that can affect patient outcomes.
Transcript
What should employers know about direct contracting in cancer care?
[They should know] that they do have an opportunity, and they do have an opportunity to take more control of their own health care costs and their health care benefits in relation to cancer. And this will allow them to eliminate a lot of the burden of some tactics by pharmacy benefit managers and insurance companies, such as preauthorization, precertification, white bagging, or brown bagging, that can cause harm to patients and also interfere with the doctor-patient relationships. And our goal is to connect them with community oncology practices, where employees live and work.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More